These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11726209)

  • 1. Analysis of chromatin-immunopurified MeCP2-associated fragments.
    El-Osta A; Wolffe AP
    Biochem Biophys Res Commun; 2001 Dec; 289(3):733-7. PubMed ID: 11726209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
    Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
    EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.
    Harikrishnan KN; Chow MZ; Baker EK; Pal S; Bassal S; Brasacchio D; Wang L; Craig JM; Jones PL; Sif S; El-Osta A
    Nat Genet; 2005 Mar; 37(3):254-64. PubMed ID: 15696166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
    Koch C; Strätling WH
    Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of protein-DNA association in vivo by chromatin immunoprecipitation.
    Kuras L
    Methods Mol Biol; 2004; 284():147-62. PubMed ID: 15173614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation.
    Im H; Grass JA; Johnson KD; Boyer ME; Wu J; Bresnick EH
    Methods Mol Biol; 2004; 284():129-46. PubMed ID: 15173613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
    Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
    Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
    Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
    Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
    Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
    Bapat S; Galande S
    Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2: the chromatin connection and beyond.
    Zlatanova J
    Biochem Cell Biol; 2005 Jun; 83(3):251-62. PubMed ID: 15959553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK; Mitra S
    Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
    Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
    Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.
    Wade PA
    Oncogene; 2001 May; 20(24):3166-73. PubMed ID: 11420733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.